Navigation Links
Neura Therapeutik Forms Business Units to Pursue Analgesic Market Opportunities
Date:7/31/2012

PRINCETON, N.J., July 31, 2012 /PRNewswire/ -- Neura Therapeutik, LLC, a privately held specialty pharmaceutical company, announced today the formation of two strategic business units to capitalize on current and future opportunities in the analgesic market. The formation of Neura Group, LLC and Neura Labs, LLC structures the company to efficiently pursue commercial services, in-licensing, and joint venture opportunities in the analgesic marketplace.

Established by former King and Pfizer executives in 2010, Neura Therapeutik brings expertise in commercialization and development of analgesics, primarily in the NSAID and opioid classes of the pain market. Management's past experience includes directing pain franchise build outs and launching some of the largest US analgesic brands including Duragesic® patch and Vicodin ES® tablets. The formation of the business units allows Neura the ability to fully leverage its expertise in the analgesic market and build strong working alliances with strategic operational partners.

Through in-licensing and joint venture arrangements, the Neura Labs business unit will focus on establishing a portfolio of analgesic products with unique characteristics that fulfill unmet market needs, reside in the opioid and more specifically the tamper-resistant segment, or that have a high therapeutic index, or other unique pharmacokinetic or functional characteristics.

The Neura Group business unit provides companies interested in entering the analgesic market with a highly experienced turn-key commercial infrastructure and leadership team capable of rapidly establishing a total US operational presence. Neura Group offers best-in-class functional area expertise in CMC, regulatory and manufacturing scale-up to sales, marketing, launch readiness and lifecycle management.

"There are many nuances associated with analgesic commercialization. A commercial team with experience navigating the US analgesic marketplace is critical for the success of any product seeking to enter this market," said John La Lota, CEO of Neura Therapeutik. "Neura Therapeutik's two strategic business units provide an efficient solution to companies requiring an analgesic experienced commercial team whether they wish to retain the asset and leverage our commercial expertise, or if they seek an experienced company as a licensing partner."

Duragesic® is a registered trademark of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Vicodin ES® is a registered trademark of Abbott Laboratories.

Contact:

Neura Therapeutik, LLC
Greg Gironda: girondag@neuratherapeutik.com 
Visit: www.neuratherapeutik.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com


'/>"/>
SOURCE Neura Therapeutik, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
2. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
3. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
4. Neuralstem Updates ALS Stem Cell Trial Progress
5. Sanovas Forms Scientific Advisory Board to Support Development of Lung Cancer Technology
6. BioSurplus Forms New Division for Auction Services
7. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
8. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
9. inVentiv Medical Management Forms Partnership with Vital Decisions
10. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
11. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... CLEVELAND , July 10, 2017  US medical ... billion in 2021, according to Medical Equipment ... released by Freedonia Focus Reports. Continued increases in demand ... the aging of the population and supported by gains ... associated equipment and supplies. New product introductions will also ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/10/2017)... 10, 2017 Locus Biosciences Inc. today announced ... the development of CRISPR-Cas3 antimicrobial therapeutics. Financing for the ... Chinese Internet services provider, and joined by the North ... disease product programs targeting antibiotic resistant infections and other ... by Dr. Rodolphe Barrangou and Dr. ...
Breaking Medicine Technology:
(Date:7/27/2017)... (PRWEB) , ... July 27, 2017 , ... ... litigation support services for 600 patent challenges worldwide, representing a milestone ... and testing services for product development, SSCI scientists have served as expert ...
(Date:7/27/2017)... ... ... isn’t always easy. Currently, more than 80 percent of Americans fail to eat the recommended ... sugar. This trend may help explain why the obesity rate seems stuck. The most recent ... culture, we seem to have food on the brain more. "We eat two more large ...
(Date:7/27/2017)... ... July 27, 2017 , ... Team Novo Nordisk, the ... to the men’s pro squad as a stagiaire for the remainder of the 2017 ... debut on July 31st at the Tour of Utah. , “Every season we are ...
(Date:7/26/2017)... PA (PRWEB) , ... July 26, 2017 , ... An ... a hospital, and I haven’t yet seen an effective and dignified way to keep ... idea for the LEECH CUP." , This invention provides an effective way to keep ...
(Date:7/26/2017)... ... 26, 2017 , ... Six greater Bay Area roller derby leagues are partnering with Brown Paper ... widely attended series of blood drives in California, beginning July 29. Make ‘Em Bleed roller ... years -- enough to have helped to save up to 2700 lives. , “The Make ...
Breaking Medicine News(10 mins):